13G Filing: Kerrisdale Capital and Adamas Pharmaceuticals Inc (ADMS)

Page 7 of 7

Page 7 of 7 – SEC Filing


SIGNATURE

After reasonable inquiry and to the best of their knowledge and belief, each of the undersigned certifies that the information set forth in this statement is
true, complete and correct.

Dated: November 1, 2017
Kerrisdale Partners Master Fund Ltd
Signature:

/s/ Sahm Adrangi

Name: Sahm Adrangi
Title: Director
Kerrisdale Advisers, LLC
Signature:

/s/ Sahm Adrangi

Name: Sahm Adrangi
Title: Managing Member

/s/ Sahm Adrangi

Sahm Adrangi

Follow Adamas Pharmaceuticals Inc (NASDAQ:ADMS)

Page 7 of 7